Key opinion leaders explore the clinical and economic burden of dementia-related psychosis and the unmet medical need.
Gary W. Small, MD, considers the burden of dementia-related psychosis for patients and their caregivers. Then, key opinion leader, Stephen A. Brunton, MD, discusses the role of caregiver engagement and outreach in managing patients with dementia-related psychosis and reviews the prevalence of neuropsychiatric symptoms in patients with dementia. Lastly, Dr Small discusses the challenges in disease management and patient considerations for pharmacologic and nonpharmacologic interventions.
The speakers are paid consultants on behalf of Acadia Pharmaceuticals Inc. This is a disease-awareness, non-CME program sponsored by Acadia Pharmaceuticals Inc.